Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C17H25NO |
| Molecular Weight | 259.3865 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCC(N1CCCC1)C(=O)C2=CC=CC=C2
InChI
InChIKey=DLRWKNLMJAIFQB-UHFFFAOYSA-N
InChI=1S/C17H25NO/c1-2-3-5-12-16(18-13-8-9-14-18)17(19)15-10-6-4-7-11-15/h4,6-7,10-11,16H,2-3,5,8-9,12-14H2,1H3
| Molecular Formula | C17H25NO |
| Molecular Weight | 259.3865 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Metabolism of α-PHP and α-PHPP in humans and the effects of alkyl chain lengths on the metabolism of α-pyrrolidinophenone-type designer drugs. | 2018 |
|
| Comments on "Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products". | 2015-06 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:20:53 GMT 2025
by
admin
on
Mon Mar 31 23:20:53 GMT 2025
|
| Record UNII |
E6220IS097
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-ALPHA-PYRROLIDINOHEPTAPHENONE
Created by
admin on Mon Mar 31 23:20:53 GMT 2025 , Edited by admin on Mon Mar 31 23:20:53 GMT 2025
|
||
|
DEA NO. |
7548
Created by
admin on Mon Mar 31 23:20:53 GMT 2025 , Edited by admin on Mon Mar 31 23:20:53 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
?-Pyrrolidinoheptaphenone
Created by
admin on Mon Mar 31 23:20:53 GMT 2025 , Edited by admin on Mon Mar 31 23:20:53 GMT 2025
|
PRIMARY | |||
|
DTXSID501016918
Created by
admin on Mon Mar 31 23:20:53 GMT 2025 , Edited by admin on Mon Mar 31 23:20:53 GMT 2025
|
PRIMARY | |||
|
100000177629
Created by
admin on Mon Mar 31 23:20:53 GMT 2025 , Edited by admin on Mon Mar 31 23:20:53 GMT 2025
|
PRIMARY | |||
|
.ALPHA.-PYRROLIDINOHEPTIOPHENONE
Created by
admin on Mon Mar 31 23:20:53 GMT 2025 , Edited by admin on Mon Mar 31 23:20:53 GMT 2025
|
PRIMARY | |||
|
PV-8
Created by
admin on Mon Mar 31 23:20:53 GMT 2025 , Edited by admin on Mon Mar 31 23:20:53 GMT 2025
|
PRIMARY | |||
|
13415-83-3
Created by
admin on Mon Mar 31 23:20:53 GMT 2025 , Edited by admin on Mon Mar 31 23:20:53 GMT 2025
|
PRIMARY | |||
|
69245534
Created by
admin on Mon Mar 31 23:20:53 GMT 2025 , Edited by admin on Mon Mar 31 23:20:53 GMT 2025
|
PRIMARY | |||
|
E6220IS097
Created by
admin on Mon Mar 31 23:20:53 GMT 2025 , Edited by admin on Mon Mar 31 23:20:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|
||
|
ENANTIOMER -> RACEMATE |
|
||
|
ENANTIOMER -> RACEMATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
